Detalles de la búsqueda
1.
Translational immune correlates of indirect antibody immunization in a randomized phase II study using scheduled combination therapy with carboplatin/paclitaxel plus oregovomab in ovarian cancer patients.
Cancer Immunol Immunother
; 69(3): 383-397, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31897661
2.
Correction to: Translational immune correlates of indirect antibody immunization in a randomized phase II study using scheduled combination therapy with carboplatin/paclitaxel plus oregovomab in ovarian cancer patients.
Cancer Immunol Immunother
; 69(7): 1389, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32219502
3.
Front-line chemo-immunotherapy with carboplatin-paclitaxel using oregovomab indirect immunization in advanced ovarian cancer: A randomized phase II study.
Gynecol Oncol
; 156(3): 523-529, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31916979
4.
Combination of mAb-AR20.5, anti-PD-L1 and PolyICLC inhibits tumor progression and prolongs survival of MUC1.Tg mice challenged with pancreatic tumors.
Cancer Immunol Immunother
; 67(3): 445-457, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29204701
5.
Discordant biological and toxicological species responses to TLR3 activation.
Am J Pathol
; 184(4): 1062-1072, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24486326
6.
A novel IgE antibody targeting the prostate-specific antigen as a potential prostate cancer therapy.
BMC Cancer
; 13: 195, 2013 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-23594731
7.
Targeting HER2/neu with a fully human IgE to harness the allergic reaction against cancer cells.
Cancer Immunol Immunother
; 61(7): 991-1003, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22127364
8.
IgE-Based Therapeutic Combination Enhances Antitumor Response in Preclinical Models of Pancreatic Cancer.
Mol Cancer Ther
; 20(12): 2457-2468, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34625505
9.
Toll-like receptor-3 as a target to enhance bioactivity of cancer immunotherapy.
Am J Obstet Gynecol
; 202(6): 608.e1-8, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20080226
10.
Phase I/II Trial of Neoadjuvant Oregovomab-based Chemoimmunotherapy Followed by Stereotactic Body Radiotherapy and Nelfinavir For Locally Advanced Pancreatic Adenocarcinoma.
Am J Clin Oncol
; 42(10): 755-760, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31513018
11.
Randomized, placebo-controlled study of oregovomab for consolidation of clinical remission in patients with advanced ovarian cancer.
J Clin Oncol
; 22(17): 3507-16, 2004 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15337799
12.
Antibody-based immunotherapy of solid cancers: progress and possibilities.
Immunotherapy
; 7(8): 923-39, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26314410
13.
Immunomodulation with antibodies: clinical application in ovarian cancer and other malignancies.
Expert Rev Vaccines
; 1(1): 35-48, 2002 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-12908511
14.
Phase I study of abagovomab in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer.
Clin Cancer Res
; 13(13): 4026; author reply 4026-7, 2007 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17606738
15.
Oregovomab maintenance monoimmunotherapy does not improve outcomes in advanced ovarian cancer.
J Clin Oncol
; 27(3): 418-25, 2009 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-19075271
16.
The Immune adjuvant properties of front-line carboplatin-paclitaxel: a randomized phase 2 study of alternative schedules of intravenous oregovomab chemoimmunotherapy in advanced ovarian cancer.
J Immunother
; 32(1): 54-65, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19307994
17.
CA125 velocity at relapse is a highly significant predictor of survival post relapse: results of a 5-year follow-up survey to a randomized placebo-controlled study of maintenance oregovomab immunotherapy in advanced ovarian cancer.
J Immunother
; 31(2): 207-14, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18481390
18.
Role of monoclonal antibodies in tumor-specific immunity.
Expert Opin Biol Ther
; 7(3): 331-43, 2007 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-17309325
19.
Monoclonal antibody therapy of ovarian cancer.
Expert Rev Anticancer Ther
; 5(1): 87-96, 2005 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-15757441
20.
TLR3 agonists as immunotherapeutic agents.
Immunotherapy
; 2(2): 137-40, 2010 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20635920